Sign in
4

Changes in Ownership

RxSight, Inc. Filed Acc 0000950170-24-117877

See remarks sold 6,200 shares at an average $50.22 ($311,354)

  • See remarks acquired 6,200 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Goldshleger Ilya See remarks 2024-10-25 Option exercise 10b5-1 +3,100 $15.08 $46,748 45,346 D: show line 1 in the form
Goldshleger Ilya See remarks 2024-10-25 Sale 10b5-1 −3,100 $49.79 $154,360 42,246 D: show line 2 in the form
Goldshleger Ilya See remarks 2024-10-28 Option exercise 10b5-1 +3,100 $15.08 $46,748 45,346 D: show line 3 in the form
Goldshleger Ilya See remarks 2024-10-28 Sale 10b5-1 −3,100 $50.64 $156,993 42,246 D: show line 4 in the form
Open-market sales · 6,200 sh · avg $50.22 · $311,354

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Goldshleger Ilya See remarks 2024-10-25 Option exercise · Stock Option (right to buy) 10b5-1 −3,100 71,792 D: show line 5 in the form
Goldshleger Ilya See remarks 2024-10-28 Option exercise · Stock Option (right to buy) 10b5-1 −3,100 68,692 D: show line 6 in the form
Loading xslF345X05/ownership.xml…